Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 8;4(1):1-19.
doi: 10.3390/jpm4010001.

Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease

Kevin Sweet  1 , Erynn S Gordon  2 , Amy C Sturm  1 , Tara J Schmidlen  3 , Kandamurugu Manickam  1 , Amanda Ewart Toland  4 , Margaret A Keller  5 , Catharine B Stack  6 , J Felipe García-España  3 , Mark Bellafante  3 , Neeraj Tayal  7 , Peter Embi  8 , Philip Binkley  9 , Ray E Hershberger  10 , Wolfgang Sadee  11 , Michael Christman  3 , Clay Marsh  12
Affiliations

Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease

Kevin Sweet et al. J Pers Med. .

Abstract

We describe the development and implementation of a randomized controlled trial to investigate the impact of genomic counseling on a cohort of patients with heart failure (HF) or hypertension (HTN), managed at a large academic medical center, the Ohio State University Wexner Medical Center (OSUWMC). Our study is built upon the existing Coriell Personalized Medicine Collaborative (CPMC®). OSUWMC patient participants with chronic disease (CD) receive eight actionable complex disease and one pharmacogenomic test report through the CPMC® web portal. Participants are randomized to either the in-person post-test genomic counseling-active arm, versus web-based only return of results-control arm. Study-specific surveys measure: (1) change in risk perception; (2) knowledge retention; (3) perceived personal control; (4) health behavior change; and, for the active arm (5), overall satisfaction with genomic counseling. This ongoing partnership has spurred creation of both infrastructure and procedures necessary for the implementation of genomics and genomic counseling in clinical care and clinical research. This included creation of a comprehensive informed consent document and processes for prospective return of actionable results for multiple complex diseases and pharmacogenomics (PGx) through a web portal, and integration of genomic data files and clinical decision support into an EPIC-based electronic medical record. We present this partnership, the infrastructure, genomic counseling approach, and the challenges that arose in the design and conduct of this ongoing trial to inform subsequent collaborative efforts and best genomic counseling practices.

Keywords: actionable; counseling; genomics; implementation; medicine; patients; pharmacogenomics; randomized; risk perception.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study schema.
Figure 2
Figure 2
Sample CPMC® coronary artery disease report.
Figure 3
Figure 3
Sample patient risk summary research report.
See this image and copyright information in PMC

References

    1. Kaphingst K.A., McBride C.M., Wade C., Alford S.H., Reid R., Larson E., Baxevanis A.D., Brody L.C. Patients’ understanding of and responses to multiplex genetic susceptibility test results. Genet. Med. 2012;14:681–687. doi: 10.1038/gim.2012.22. - DOI - PMC - PubMed
    1. Dong H., Wang S. Exploring the cancer genome in the era of next-generation sequencing. Front. Med. 2012;6:48–55. doi: 10.1007/s11684-012-0182-x. - DOI - PubMed
    1. Pinto N., Cohn S.L., Dolan M.E. Using germline genomics to individualize pediatric cancer treatments. Clin. Cancer Res. 2012;18:2791–2800. doi: 10.1158/1078-0432.CCR-11-1938. - DOI - PMC - PubMed
    1. Ingelman-Sundberg M., Sim S.C. Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome p450 system. Biochem. Biophys. Res. Commun. 2010;396:90–94. doi: 10.1016/j.bbrc.2010.02.162. - DOI - PubMed
    1. Korf B.R., Rehm H.L. New approaches to molecular diagnosis. JAMA. 2013;309:1511–1521. doi: 10.1001/jama.2013.3239. - DOI - PubMed

LinkOut - more resources